Vulvar basal cell carcinoma: clinical features and treatment outcomes from a tertiary care centre.
- Author:
Rama P NAMUDURI
1
;
Timothy Yk LIM
1
;
Philip Kl YAM
1
;
Rene GATSINGA
2
;
Soo Kim LIM-TAN
3
;
Sung Hock CHEW
3
;
Mark Ja KOH
4
;
Sorsiah MANSOR
3
Author Information
- Publication Type:Journal Article
- Keywords: basal cell carcinoma; neoplasm; vulvar
- From:Singapore medical journal 2019;60(9):479-482
- CountrySingapore
- Language:English
- Abstract: We retrospectively reviewed the clinical features, management and outcomes of patients diagnosed with basal cell carcinoma (BCC) of the vulva at the Gynaecological Cancer Centre, KK Women's and Children's Hospital, Singapore, between 1 January 2000 and 28 February 2014. Patients with vulvar BCC were identified from the cancer registry, and their medical records reviewed and analysed. A total of 11 patients with vulvar BCC were identified. Mean age at diagnosis was 63 (range 30-85) years. Ethnically, ten patients were Chinese and one was Malay. Average time from onset of symptoms to diagnosis was 13.8 (range 2-60) months. The most common presenting symptoms were lump and pruritus. All patients were managed surgically. Recurrence was noted in only one patient. Vulvar BCC, although rare, has an excellent prognosis when managed appropriately. Histological diagnosis of all persistent papules, plaques and pigmented lesions is important for early diagnosis.
